Spots Global Cancer Trial Database for Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma
Official Title: A Randomized Phase II Trial of Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma or Who Are Unfit for Standard Therapy
Study ID: NCT01097083
Interventions
Study Description
Brief Summary: The hypothesis of this study is that the median time to progression in the experimental arm is 2 months as compared to the placebo arm of 1.4 months
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National University Hospital, Singapore, , Singapore
Singapore General Hospital, Singapore, , Singapore
National Cancer Centre, Singapore, , Singapore
Contact Details
Name: Wei Peng Yong, MRCP, MB ChB'
Affiliation: National University Hospital, Singapore
Role: PRINCIPAL_INVESTIGATOR
Name: Choo Su Pin, BMBS, MRCP, M Med
Affiliation: National Cancer Centre
Role: PRINCIPAL_INVESTIGATOR
Name: Tan Chee Kiat, MBBS, FRCP, FAMS
Affiliation: Singapore General Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
